Next Article in Journal
Contrast Enhancement-Based Preprocessing Process to Improve Deep Learning Object Task Performance and Results
Next Article in Special Issue
Immuno-PET for Glioma Imaging: An Update
Previous Article in Journal
Physiological Profile and Correlations between VO2max and Match Distance Running Performance of Soccer Players with Visual Impairment
Previous Article in Special Issue
A Resveratrol Phenylacetamide Derivative Perturbs the Cytoskeleton Dynamics Interfering with the Migration Potential in Breast Cancer
 
 
Article
Peer-Review Record

Comparative Study of the Anticancer Effects of Selenium Nanoparticles and Selenium Nanorods: Regulation of Ca2+ Signaling, ER Stress and Apoptosis

Appl. Sci. 2023, 13(19), 10763; https://doi.org/10.3390/app131910763
by Elena G. Varlamova 1,*, Ilya V. Baimler 2, Sergey V. Gudkov 2 and Egor A. Turovsky 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Appl. Sci. 2023, 13(19), 10763; https://doi.org/10.3390/app131910763
Submission received: 26 August 2023 / Revised: 19 September 2023 / Accepted: 26 September 2023 / Published: 27 September 2023
(This article belongs to the Special Issue Targeting Cellular Key Points in Drug Discovery)

Round 1

Reviewer 1 Report

This is an interesting study looking at the effect of either selenium nanoparticles or selenium nanorods on the human glioblastoma cancer cell line A-172 in comparison to a mouse fibroblast cell line L-929. The authors determined that selenium nanorods were more effective at inducing apoptosis then selenium nanoparticles without inducing necrosis in A-172 cells. The authors suggest this is due to calcium rise in which correlates with increased pro-apoptotic genes in the A-172 cells but not the L-929 cells. While interesting, I believe the study could be improved by a direct comparison between a human cancer cell line and a human fibroblast cell line rather than a mouse. 

Specific Comments:

1. Need to include author contributions, IRB approval and funding sources. All three are missing.

2. Figures 4 and 5 - It would be helpful to have a bold label indicating which cell line was used for each figure. Otherwise, it is a little confusing as presented as to which cell line is being used to assess the impact of the SeNrs and SeNPs on apoptosis and necrosis in these cell lines. 

3. A-172 is a human glioblastoma cell line while L-929 is a mouse fibroblast cell line. Why not use a human fibroblast cell line to compare the impact of the SeNPs and SeNrs? Differences in results between the two cell lines could be simply due to the use of two different species.  

Some minor grammatical errors, otherwise quality of English language is generally good. 

Author Response

Reviewer #1

 

Comments 1.1

Need to include author contributions, IRB approval and funding sources. All three are missing.

Reply 1.1

We thank the reviewer for taking the time to read our manuscript and for his valuable comments. We have added author contributions, IRB approval and funding sources to the text of the manuscript.

 

Comments 1.2

Figures 4 and 5 - It would be helpful to have a bold label indicating which cell line was used for each figure. Otherwise, it is a little confusing as presented as to which cell line is being used to assess the impact of the SeNrs and SeNPs on apoptosis and necrosis in these cell lines. 

Reply 1.2

We agree. Thank you. Added

 

Comments 1.3

A-172 is a human glioblastoma cell line while L-929 is a mouse fibroblast cell line. Why not use a human fibroblast cell line to compare the impact of the SeNPs and SeNrs? Differences in results between the two cell lines could be simply due to the use of two different species.  

Reply 1.3

We agree with the opinion of the respected reviewer. The objective of this work was to compare the effects of two types of nanoparticles on cancer and “healthy” cells. Of course, it would be more correct if we used human fibroblasts, but it is extremely difficult for us to obtain such a cell line in the foreseeable future. One might suggest using the human HEK-293 cell line, which is used in a number of studies, as a control. However, there is growing evidence that these cells cannot be characterized as “healthy”. These cells are characterized as a non-cancerous, but oncogenic cell line. In view of the similarity of most physiological and pathophysiological processes in humans and mice, a comparative analysis of the effects of nanoparticles relative to a mouse cell line can be considered acceptable.

 

Reviewer 2 Report

The manuscript entitled “Comparative study of the anticancer effects of selenium nanoparticles and selenium Nanorods. Regulation of Ca2+ signaling, ER stress and apoptosis” deals with the therapeutic potential of selenium nanoparticles an nanorods. The therapeutic usage of nanomaterials is a hot topic in cancer research, falls within the scope of the journal and would be interesting for the general readership.

The manuscript is well structured, and the applied methodology is adequate and the main results are clearly presented. Apart from language editing, some minor changes are required:

-       Please rephrase the sentence in lines 45 and 46, since the meaning is greatly affected by the grammar and syntax errors.

-       Please use g force beside rpm for centrifuge speed in line 107, since it is more informative.

-       More details about the PCR procedure are required (e.g. primer sequences), since the cited article does not contain all the relevant data.

-       The first sentence of the Conclusions section can be deleted, since it is more related to the applied methodology, instead of pointing out the main results from comparing the anticancer activities of two types of nanoparticles.

 

Minor-to-moderate English editing is required, since some of the parts of the manuscript are difficult to understand, or have the meaning which is opposite  to the intended.

Author Response

Reviewer #2

 

Comment 2.1

Please rephrase the sentence in lines 45 and 46, since the meaning is greatly affected by the grammar and syntax errors.

Reply 2.1

We thank the reviewer for taking the time to read our manuscript and for his valuable comments. Thank you. Paraphrased. (However, these methods have a number of side effects - toxic effects on healthy organs and tissues).

 

Comment 2.2

Please use g force beside rpm for centrifuge speed in line 107, since it is more informative.

Reply 2.2

Added (4200 rpm, rotor radius 0.12 m, Relative Centrifugal Force ~2400 g).

 

Comment 2.3

More details about the PCR procedure are required (e.g. primer sequences), since the cited article does not contain all the relevant data.

Reply 2.3

Primer sequences added (Table 1, 2)

 

Table 1

Primers for the synthesis of human mRNA fragments

Gene name

Forward primer 5'–>

Reverse primer 5'–>3

GAPDH

ACATCGCTCAGACACCATG

GCCAGTGAGCTTCCCGTT

SELENOT

TCTCCTAGTGGCGGCGTC

GTCTATATATTGGTTGAGGGAGG

SELENOM

AGCCTCCTGTTGCCTCCGC

AGGTCAGCGTGGTCCGAAG

SELENOF

GGAGGAAGCACAATTTGAAACC

TATGCGTTCCAACTTTTCACTC

SELENOK

TTTACATCTCGAACGGACAAG

CAGCCTTCCACTTCTTGATG

SELENOS

TGGGACAGCATGCAAGAAG

GCGTCCAGGTCTCCAGG

SELENON

TGATCTGCCTGCCCAATG

TCAGGAACTGCATGTAGGTGG

DIO2

AGCTTCCTCCTCGATGCC

AAAGGAGGTCAAGTGGCTG

CHOP

GCTCTGATTGACCGAATGG

TCTGGGAAAGGTGGGTAGTG

GADD34

CTCCGAGAAGGTCACTGTCC

GACGAGCGGGAAGGTGTGG

PUMA

CAGATATGCGCCCAGAGAT

CCATTCGTGGGTGGTCTTC

BIM

GGACGACCTCAACGCACAGTACGAG

GTAAGGGCAGGAGTCCCA

CAS–3

GCATTGAGACAGACAGTGGTG

AATAGAGTTCTTTTGTGAGCATG

CAS–4

CACGCCTGGCTCTCATCATA

TAGCAAATGCCCTCAGCG

BAX

GGGCTGGACATTGGACTTC

AACACAGTCCAAGGCAGCTG

BAK

GAGAGTGGCATCAATTGGGG

CAGCCACCCCTCTGTGCAATCCA

BCL-2

GGTGAACTGGGGGAGGATTG

AGCCAGGAGAAATCAAACAGAG

ATF–4

GTGTTCTCTGTGGGTCTGCC

GACCCTTTTCTTCCCCCTTG

ATF–6

AACCCTAGTGTGAGCCCTGC

GTTCAGAGCACCCTGAAGA

XBPu

ACTCAGACTACGTGCACCTC

GTCAATACCGCCAGAATCC

XBPs

CTGAGTCCGCAGCGGTGCAGG

GGTCCAAGTTGTCCAGAATG

GPX1

AAGATCCAACCCAAGGGCAAG

CATGAGTGCCGGTGGAAGG

GPX4

AAGATCCAACCCAAGGGCAAG

CATGAGTGCCGGTGGAAGG

TXNRD1

CAACAAATGTTATGCAAAAATAATC

ACACTGGGGCTTAACCTCAG

TXNRD3

CTCTTTAGAAAAGTGTGATTATATT

GCCCACATTTCATTGCAGCTG

Nf-kB

TACTTTCTCACTTTTTGCCCAC

GGTCTACAGGAAGGCGTGG

 

 

 

Table 2

Primers for the synthesis of mouse mRNA fragments

Gene name

Forward primer 5'–>

Reverse primer 5'–>3

GAPDH

AAGGTGGTGAAGCAGGCATC

CTCTTGCTCAGTGTCCTTGC

SELENOT

TGATTGAGAACCAGTGTATGTC

GGTACAACGAGCCTGCCAAG

SELENOM

CGCCTAAAGGAGGTGAAGGC

CTTGCGGTAGAAGCCGAGCTC

SELENOF

AGGGTGCTGTCAGGAAGAAG

CGTTCCAACTTCTCGCTCAG

SELENOK

GAAGAGGGCCACCAGGAAAC

GGAATTCCCAGCATGACCTC

SELENOS

GGACCAAGCCGAGACTGTTC

CTTCTTGCATGCTGTCCCAC

SELENON

AAGATGGCTTCCTAGGGGTC

CTGAGGGGCAAAGCGGGTC

DIO2

GCTTATCTCTGCCCCCATTG

CACACATAAACGACCTCCTTC

CHOP

CAGCTGGGAGCTGGAAGCCTG

GACCACTCTGTTTCCGTTTCC

GADD34

GAGTCCCATGAAGAGATTGTAC

ACCAGCCCAGCAGCACTTAG

PUMA

TGAAGATCTGCGCCGGGAG

GAGAGGGACATGACGCGTG

BIM

AATGGCCGGCTATGGATGATG

GCCAATTGGGTTCACTGTCTG

CAS–3

GACCCGTCCTTTGAATTTCTC

CTCTTCATCATTCAGGCCTGC

CAS–4

TTTTCTTTTCTTCTCAGCTACAG

TGTTGGTGTTATCATTTGGAGG

BAX

TAAAGTGCCCGAGCTGATCAGAAC

CTTCCCAGCCACCCTGGTCTT

BAK

CAGATGGATCGCACAGAGAG

GCGTCTTTGCCCTGGGGAG

BCL-2

GGTGAACTGGGGGAGGATTG

AGCCAGGAGAAATCAAACAGAG

ATF–4

TCGGGTTTGGGGGCTGAAG

AAACAGAGCATCGAAGTCAAAC

ATF–6

AGGAGGGGAGATACGTTTTAC

CGAGGAGCTTTTGATGTGGAG

XBPu

GAGTCCGCAGCAGAGTCCGCAGC

GGAGGCTGGTAAGGAACTAG

XBPs

AGTCCGCAGCACAGCAGGT

AGAGAAAGGGAGGCTGGTAAG

GPX1

GGGGAGCCTGTGAGCCTGG

GGACGTACTTGAGGGAATTC

GPX4

GATGAAAGTCCAGCCCAAGG

GAAGGCTCCAGGGGTCACAG

TXNRD1

CAACAAATGTTATGCAAAAATAATC

ACACTGGGGCTTAACCTCAG

TXNRD3

CTCTTTAGAAAAGTGTGATTATATT

GCCCACATTTCATTGCAGCTG

Nf-kB

AAGTGCAAAGGAAACGCCAGAA

ACTACCGAACATGCCTCCACCA

 

Comment 2.4

The first sentence of the Conclusions section can be deleted, since it is more related to the applied methodology, instead of pointing out the main results from comparing the anticancer activities of two types of nanoparticles.

Reply 2.4

Deleted

 

Back to TopTop